1. Home
  2. RAPP vs DHIL Comparison

RAPP vs DHIL Comparison

Compare RAPP & DHIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RAPP
  • DHIL
  • Stock Information
  • Founded
  • RAPP 2022
  • DHIL 1990
  • Country
  • RAPP United States
  • DHIL United States
  • Employees
  • RAPP N/A
  • DHIL N/A
  • Industry
  • RAPP
  • DHIL Investment Managers
  • Sector
  • RAPP
  • DHIL Finance
  • Exchange
  • RAPP Nasdaq
  • DHIL Nasdaq
  • Market Cap
  • RAPP 439.4M
  • DHIL 392.1M
  • IPO Year
  • RAPP 2024
  • DHIL 1995
  • Fundamental
  • Price
  • RAPP $14.71
  • DHIL $143.54
  • Analyst Decision
  • RAPP Strong Buy
  • DHIL
  • Analyst Count
  • RAPP 3
  • DHIL 0
  • Target Price
  • RAPP $33.67
  • DHIL N/A
  • AVG Volume (30 Days)
  • RAPP 162.2K
  • DHIL 27.1K
  • Earning Date
  • RAPP 08-07-2025
  • DHIL 07-29-2025
  • Dividend Yield
  • RAPP N/A
  • DHIL 4.18%
  • EPS Growth
  • RAPP N/A
  • DHIL 21.42
  • EPS
  • RAPP N/A
  • DHIL 17.58
  • Revenue
  • RAPP N/A
  • DHIL $151,281,009.00
  • Revenue This Year
  • RAPP N/A
  • DHIL N/A
  • Revenue Next Year
  • RAPP N/A
  • DHIL N/A
  • P/E Ratio
  • RAPP N/A
  • DHIL $8.16
  • Revenue Growth
  • RAPP N/A
  • DHIL 6.29
  • 52 Week Low
  • RAPP $6.43
  • DHIL $122.32
  • 52 Week High
  • RAPP $29.74
  • DHIL $173.25
  • Technical
  • Relative Strength Index (RSI)
  • RAPP N/A
  • DHIL 46.42
  • Support Level
  • RAPP N/A
  • DHIL $139.60
  • Resistance Level
  • RAPP N/A
  • DHIL $149.02
  • Average True Range (ATR)
  • RAPP 0.00
  • DHIL 3.73
  • MACD
  • RAPP 0.00
  • DHIL 0.22
  • Stochastic Oscillator
  • RAPP 0.00
  • DHIL 57.03

About RAPP Rapport Therapeutics Inc. Common Stock

Rapport Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovery and development of transformational small-molecule medicines for patients suffering from central nervous system disorders. Its foundational science has elucidated the complexities of neuronal receptor biology and enables the company to map and target certain neuronal receptor complexes. Neuronal receptors are complex assemblies of proteins, comprising receptor principal subunits and their receptor-associated proteins (RAPs), the latter of which play crucial roles in regulating receptor expression and function.

About DHIL Diamond Hill Investment Group Inc.

Diamond Hill Investment Group Inc sponsors, markets, and provides investment advisory and related services to various U.S. and foreign clients including mutual funds, separate accounts, and private investment funds. The company's objective is to fulfill a fiduciary duty to clients and secondary objectives to achieve an adequate long-term return for shareholders. The company generates its revenue from Investment advisory and fund administration fees.

Share on Social Networks: